MediWound Ltd (MDWD) is a biopharmaceutical company that specializes in developing innovative therapies for severe burns and chronic wounds. The company's advanced wound care products are designed to promote the healing process and improve the quality of life for patients suffering from these debilitating conditions.

In order to assess the current market trends and potential future performance of MediWound Ltd stock, it is important to analyze various technical indicators. One such indicator is the Relative Strength Index (RSI), which measures the strength and momentum of a stock's price movement. A high RSI value indicates that the stock is overbought, while a low value suggests that it is oversold.

MediWound Ltd (MDWD) Technical Analysis

Explore the technical indicators of MediWound Ltd (MDWD) stock, including RSI, ADX, MACD, ROC, STOCHRSI, and WILLR. Gain insights into the stock's performance and make informed investment decisions. Discover potential opportunities and navigate market trends with our comprehensive technical analysis. Stay updated with the latest trends and indicators for MediWound Ltd.

MediWound Ltd (MDWD) Technical Analysis | RSI, ADX, MACD, ROC, STOCHRSI, WILLR

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

MediWound Ltd

NASDAQ

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Balanced or Uncertain

MACD

WILLR

STOCHRSI

Free

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

Name	Value	Action	infoPnL (10y)
auto_graphRSI	61.93	Neutral	13.3%
auto_graphMACD	0.99	Neutral	-65.2%
auto_graphCCI	148.12	Sell	379.4%
auto_graphADX	18.09	Neutral	-59.8%
auto_graphATR	3.97	Buy	-
auto_graphWILLR	-3.03	Sell	112.4%
auto_graphROC	34.97	Neutral	-69.9%
auto_graphSTOCHRSI	100.00	Sell	-21.6%

Buy	1	-87.50%
Hold	4	-50.00%
Sell	3	-62.50%

Trendlines, Support and Resistance

Welcome to Stocklytics

Technical Indicators

Indicator Ratings

Balanced or Uncertain

MediWound Ltd (MDWD) Technical Analysis

Keep an eye on MediWound Ltd

Frequently Asked Questions

What are the technical signals for MediWound Ltd (MDWD) stock based on the last 30 days?

Take Your Investments to a Whole New Level